These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 10953327)
41. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin. Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813 [TBL] [Abstract][Full Text] [Related]
42. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78. Chatterjee S; Hirota H; Belfi CA; Berger SJ; Berger NA Cancer Res; 1997 Nov; 57(22):5112-6. PubMed ID: 9371511 [TBL] [Abstract][Full Text] [Related]
43. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards. Souliotis VL; Dimopoulos MA; Sfikakis PP Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520 [TBL] [Abstract][Full Text] [Related]
44. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo. Caffrey PB; Zhang Y; Frenkel GD Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503 [TBL] [Abstract][Full Text] [Related]
45. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Täger M; Kröning H; Thiel U; Ansorge S Exp Hematol; 1997 Jul; 25(7):601-7. PubMed ID: 9216735 [TBL] [Abstract][Full Text] [Related]
46. DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia. Müller MR; Buschfort C; Thomale J; Lensing C; Rajewsky MF; Seeber S Clin Cancer Res; 1997 Nov; 3(11):2055-61. PubMed ID: 9815597 [TBL] [Abstract][Full Text] [Related]
47. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Hansson J; Lewensohn R; Ringborg U; Nilsson B Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896 [TBL] [Abstract][Full Text] [Related]
48. Decreased L system amino acid transport and decreased gamma-glutamyl transpeptidase are independent processes in human chronic lymphocytic leukemia B-lymphocytes. Woodlock TJ; Brown R; Mani M; Pompeo L; Hoffman H; Segel GB; Silber R J Cell Physiol; 1990 Nov; 145(2):217-21. PubMed ID: 1978835 [TBL] [Abstract][Full Text] [Related]
49. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055 [TBL] [Abstract][Full Text] [Related]
50. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro. Begleiter A; Leith MK; Johnston JB Cancer Res; 1994 Jan; 54(2):482-6. PubMed ID: 8275485 [TBL] [Abstract][Full Text] [Related]
51. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380 [TBL] [Abstract][Full Text] [Related]
52. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621 [TBL] [Abstract][Full Text] [Related]
53. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742 [TBL] [Abstract][Full Text] [Related]
54. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme. Wang W; Liu G; Zheng J Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556 [TBL] [Abstract][Full Text] [Related]
55. Mechanisms of cross-resistance between radiation and antineoplastic drugs. Ozols RF; Masuda H; Hamilton TC NCI Monogr; 1988; (6):159-65. PubMed ID: 3352759 [TBL] [Abstract][Full Text] [Related]
56. DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one. Gibson NW; Hickman JA; Erickson LC Cancer Res; 1984 May; 44(5):1772-5. PubMed ID: 6713381 [TBL] [Abstract][Full Text] [Related]
57. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285 [TBL] [Abstract][Full Text] [Related]
58. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine. Xie J; Shults K; Flye L; Jiang F; Head DR; Briggs RC J Cell Biochem; 2005 May; 95(2):339-51. PubMed ID: 15778998 [TBL] [Abstract][Full Text] [Related]
59. Interpreting cell cycle effects of drugs: the case of melphalan. Lupi M; Cappella P; Matera G; Natoli C; Ubezio P Cancer Chemother Pharmacol; 2006 Apr; 57(4):443-57. PubMed ID: 16195878 [TBL] [Abstract][Full Text] [Related]
60. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB. Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]